About MLG Support

This author has not yet filled in any details.
So far MLG Support has created 78 blog entries.

Means-Plus-Function and Antibody Patent Claims: Preparing, Defending, and Enforcing MPF Claims

Marbury Law Group is pleased to announce that Partner Michelle O'Brien, Senior Partner Tom Irving, and Senior Counsel Dr. Barb Carter will present, along with others, a Strafford webinar on the topic of “Means-Plus-Function and Antibody Patent Claims: Preparing, Defending, and Enforcing MPF Claims” at 1:00 p.m. EDT on Thursday, September 14, 2023.  They will discuss, [...]

2023-09-07T13:34:38-05:00September 7, 2023|Firm News|

Federal Circuit Refuses Patentee’s Request to Revive Term-Adjusted Patent Claims Held Unpatentable for Obviousness-Type Double Patenting

By Michelle E. O’Brien and Tom Irving   The Court of Appeals for the Federal Circuit today affirmed the U.S. Patent Office’s findings that claims in four patents were unpatentable because they are not patentably distinct from claims in other patents in the same family.  In re Cellect, LLC, Nos. 2022-1293, 2022-1294, 2022-1295, 2022-1296 (August [...]

Prosecution and Specification Statements: Implications for Patent Claim Construction in Parent and Sibling Applications and PTAB and District Court/Federal Circuit Litigation

Marbury Senior Partner Tom Irving and Partner Michelle E. O'Brien will be co-presenting a webinar titled "Prosecution and Specification Statements: Implications for Patent Claim Construction in Parent and Sibling Applications and PTAB and District Court/Federal Circuit Litigation" on August 24, 2023, at 1:00 p.m. ET.  The webinar will discuss how statements in the patent specification and [...]

2023-08-18T12:28:51-05:00August 18, 2023|Firm News|

Proving and Avoiding Inequitable Conduct and Unclean Hands in Patent Prosecution and Litigation

Marbury Senior Partner Tom Irving will be co-presenting a Strafford Webinar titled "Proving and Avoiding Inequitable Conduct and Unclean Hands in Patent Prosecution and Litigation" on August 17, 2023, from 1:00-2:30 p.m. Eastern time.  The webinar will be helpful for patent counsel to understand the types of activities that may lead to a finding of [...]

2023-08-14T12:42:43-05:00August 14, 2023|Firm News|

Federal Circuit Takes Rare Step of Sending Issue of Obviousness Back to PTAB in Ex Parte Appeal

By Scott Amankwatia, Michelle E. O’Brien, and Tom Irving The United States Court of Appeals for the Federal Circuit vacated and remanded the Patent Trial and Appeal Board’s decision in an ex parte appeal affirming the U.S. Patent Office Examiner’s rejection of claims 1-13, 16, 22-24, and 27 of U.S. Patent Application No. 15/909,314 as [...]

2023-08-11T11:27:01-05:00August 11, 2023|Court Cases, Patent|

ChatGPT and NLP in Patent Prosecution

We are excited to announce that Ben Mazahery and David Hyams will be presenting in the upcoming Strafford live webinar, "ChatGPT and NLP in Patent Prosecution" on Thursday, July 20, 1:00pm-2:30pm EDT. Click this link for more information: ChatGPT and Natural Language Processors in Patent Prosecution | CLE Webinar | Strafford (straffordpub.com)

2023-07-19T16:54:35-05:00July 19, 2023|Firm News|

Marbury is Hiring!

Marbury Law Group is hiring patent attorneys and patent agents with experience in one or more of the following areas:  electrical engineering, computer engineering, computer science, wireless communication systems, or electromechanical systems; semiconductor devices and processing; and chemistry, biochemistry, and/or pharmaceuticals.  The positions will focus mainly on virtual meetings with inventors to receive invention disclosures and [...]

2023-07-12T14:01:58-05:00July 12, 2023|Firm News|

Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World: Evaluating the Effect of a Skinny Label, Implications of GSK v. Teva

Marbury Partner Michelle O’Brien and Senior Partner, Tom Irving, will be participating on a panel in the Strafford webinar entitled “Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World: Evaluating the Effect of a Skinny Label, Implications of GSK v. Teva”. Michelle and Tom will be discussing the following cases: Amarin Pharma v. Hikma Pharms. USA Inc., No. 20-1630 (D. [...]

2023-06-27T14:10:51-05:00June 27, 2023|Firm News|

U.S. Supreme Court Finds Against Amgen: The More You Claim the More You Must Enable; The Result of Being too Obscure, Loose, and Imperfect

By Tom Irving and Michelle E. O’Brien   In a much-anticipated decision, today the Supreme Court affirmed invalidity of two Amgen patents in Amgen Inc., et al. v. Sanofi, et al. (Case No. 21-757), with Justice Gorsuch writing for a unanimous Court.  The case is of particular interest because it pits one brand pharma company, [...]

2023-05-18T15:37:09-05:00May 18, 2023|Court Cases, Court Decisions, Patent|

U.S. Supreme Court Denies Teva’s Petition for Certiorari in Skinny Label Case

By Tom Irving and Michelle E. O’Brien   As the co-authors predicted in their presentation at the IPO annual meeting last year, today the Supreme Court denied certiorari in Teva Pharms. USA, Inc. v. GlaxoSmithKline LLC, Case No. 22-37.  The materials presented during that meeting, which were prepared with the assistance of Stacy Lewis of [...]

2023-05-16T07:02:01-05:00May 15, 2023|Court Decisions|
Go to Top